Supply Chain Intern (Summer 2026) at Clairo

St Joseph, Missouri, United States

Clairo Logo
Not SpecifiedCompensation
InternshipExperience Level
InternshipJob Type
NoVisa
Automotive, Manufacturing, MarineIndustries

Requirements

  • Currently enrolled as a full-time student at an accredited U.S. college or university
  • Pursuing an undergraduate degree in Supply Chain or related field
  • Authorized to work for any employer in the US without need for sponsorship, now or in the future
  • Available for Summer 2026 (up to 40 hours per week)
  • Able to work on-site at manufacturing facility in St. Joseph, MO

Responsibilities

  • Increase DOH (Days of Inventory on Hand)
  • Increase run sizes
  • Improve accuracy
  • Assist with Inventory Reconciliations
  • Eliminate wet plates
  • Decrease scrap cost
  • Learn to release production schedules
  • Create changeover matrix
  • Achieve scheduling attainment

Skills

Key technologies and capabilities for this role

Supply Chain ManagementInventory ReconciliationProduction SchedulingScrap ReductionChangeover MatrixScheduling AttainmentRun Size OptimizationDOH Reduction

Questions & Answers

Common questions about this position

What are the working arrangements for this internship?

The position is on-site based at the manufacturing facility in St. Joseph, MO.

What are the eligibility requirements for this Supply Chain Intern role?

Applicants must be currently enrolled as a full-time student at an accredited U.S. college or university, pursuing an undergraduate degree in Supply Chain or a related field, and authorized to work in the US without sponsorship.

What is the duration and time commitment for the internship?

The internship is for Summer 2026, up to 40 hours per week, with part-time during the school year possibly available.

What benefits or perks does Clarios offer?

The HQ location offers LEED certification for sustainability, a full-service cafeteria, and workout facility. Clarios has been recognized as one of 2025's Most Ethical Companies by Ethisphere for the third consecutive year.

What makes a strong candidate for this internship?

Clarios encourages applicants whose experience is close to the listed requirements, valuing diversity of experience and skills combined with passion. People from all backgrounds, including veterans and military spouses, are encouraged to apply.

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters
1972Year Founded
$29.9MTotal Funding
GROWTH_EQUITY_VCCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees

Benefits

Competitive and equitable total rewards package
Physical, mental and financial health and wellness
Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.
The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.
AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.
The company has nearly 50 years of experience in clinical trial technology solutions.
Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.
The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.
Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI